| Joseph Myers, OD | |
|
12361 W Bola Dr Ste 100, Surprise, AZ 85378-9021 | |
| (602) 767-4124 | |
| (602) 767-4125 |
| Full Name | Joseph Myers |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 18 Years |
| Location | 12361 W Bola Dr Ste 100, Surprise, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184781841 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 1558 (Arizona) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Scottsdale Center For Sight, Plc | 6305829789 | 7 |
News Archive
Increased use of computers to create predictive models of human disease is likely following a workshop organised by the European Science Foundation (ESF), which urged for a collaborative effort between specialists in the field.
Team sports have a long history of fostering cooperation, camaraderie and a healthy competitive spirit among athletes. But the closeness that brings athletes together also can create an environment for a host of contagious skin infections. Now, dermatologists are urging teammates and coaches to be aware of the most common skin conditions caused by bacteria, viruses and fungi that occur in athletes and educating them on how to prevent a widespread outbreak.
According to researchers cancer may soon be detectable using a breath test. They are now developing sensors that can detect chemical markers of lung, breast, bowel and prostate cancer in a person's breath. The new portable device has been purported as an "electronic nose" that can detect early cancers. As a cancer grows, the surface of the cells emits chemicals. The research found that sensors – involving gold nanoparticles – could be used to detect these chemicals in the breath.
One in eight physicians have been inactive in the state where they are licensed for at least a year, and most states do not require them to undergo competency tests or retraining when they return to actively practicing medicine.
Cardium Therapeutics (NYSE Amex: CXM) today announced that all patients enrolled in the Company's MATRIX clinical study have now completed their initial 12-week evaluation period and that it plans to provide detailed safety and efficacy data in late September 2009.
› Verified 5 days ago
| Provider Name | Scottsdale Center For Sight, Plc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1265591374 PECOS PAC ID: 6305829789 Enrollment ID: O20040608000525 |
News Archive
Increased use of computers to create predictive models of human disease is likely following a workshop organised by the European Science Foundation (ESF), which urged for a collaborative effort between specialists in the field.
Team sports have a long history of fostering cooperation, camaraderie and a healthy competitive spirit among athletes. But the closeness that brings athletes together also can create an environment for a host of contagious skin infections. Now, dermatologists are urging teammates and coaches to be aware of the most common skin conditions caused by bacteria, viruses and fungi that occur in athletes and educating them on how to prevent a widespread outbreak.
According to researchers cancer may soon be detectable using a breath test. They are now developing sensors that can detect chemical markers of lung, breast, bowel and prostate cancer in a person's breath. The new portable device has been purported as an "electronic nose" that can detect early cancers. As a cancer grows, the surface of the cells emits chemicals. The research found that sensors – involving gold nanoparticles – could be used to detect these chemicals in the breath.
One in eight physicians have been inactive in the state where they are licensed for at least a year, and most states do not require them to undergo competency tests or retraining when they return to actively practicing medicine.
Cardium Therapeutics (NYSE Amex: CXM) today announced that all patients enrolled in the Company's MATRIX clinical study have now completed their initial 12-week evaluation period and that it plans to provide detailed safety and efficacy data in late September 2009.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joseph Myers, OD 12361 W Bola Dr Ste 100, Surprise, AZ 85378-9021 Ph: (602) 767-4124 | Joseph Myers, OD 12361 W Bola Dr Ste 100, Surprise, AZ 85378-9021 Ph: (602) 767-4124 |
News Archive
Increased use of computers to create predictive models of human disease is likely following a workshop organised by the European Science Foundation (ESF), which urged for a collaborative effort between specialists in the field.
Team sports have a long history of fostering cooperation, camaraderie and a healthy competitive spirit among athletes. But the closeness that brings athletes together also can create an environment for a host of contagious skin infections. Now, dermatologists are urging teammates and coaches to be aware of the most common skin conditions caused by bacteria, viruses and fungi that occur in athletes and educating them on how to prevent a widespread outbreak.
According to researchers cancer may soon be detectable using a breath test. They are now developing sensors that can detect chemical markers of lung, breast, bowel and prostate cancer in a person's breath. The new portable device has been purported as an "electronic nose" that can detect early cancers. As a cancer grows, the surface of the cells emits chemicals. The research found that sensors – involving gold nanoparticles – could be used to detect these chemicals in the breath.
One in eight physicians have been inactive in the state where they are licensed for at least a year, and most states do not require them to undergo competency tests or retraining when they return to actively practicing medicine.
Cardium Therapeutics (NYSE Amex: CXM) today announced that all patients enrolled in the Company's MATRIX clinical study have now completed their initial 12-week evaluation period and that it plans to provide detailed safety and efficacy data in late September 2009.
› Verified 5 days ago
Jesse Austin Lam, OD Optometrist Medicare: Medicare Enrolled Practice Location: 13371 W Grand Ave Ste 102, Surprise, AZ 85374 Phone: 623-556-8083 | |
Eyemasters Optometrist Medicare: Not Enrolled in Medicare Practice Location: 13371 W Grand Ave, Ste. 102, Surprise, AZ 85374 Phone: 623-556-8038 | |
Dr. Sara Beth Ornstein, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 15033 W Bell Rd, Suite 150, Surprise, AZ 85374 Phone: 623-533-4697 Fax: 623-533-4907 | |
Daniel David Ziemann, OD Optometrist Medicare: Medicare Enrolled Practice Location: 13641 N Prasada Pkwy Ste 100, Surprise, AZ 85388 Phone: 623-401-1275 | |
Tom Sowash O.d. & Associates, P.c. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 13641 N Prasada Pkwy Ste 100, Surprise, AZ 85388 Phone: 726-444-4545 | |
Dr. Paige Renae Blom, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 16860 W Waddell Rd Ste 102, Surprise, AZ 85388 Phone: 602-643-4054 |